Related references
Note: Only part of the references are listed.Age-related mutations and chronic myelomonocytic leukemia
C. C. Mason et al.
LEUKEMIA (2016)
Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia
Chiara Elena et al.
BLOOD (2016)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
Myeloproliferative neoplasms (BCR-ABL1 negative) and myelodysplastic/myeloproliferative neoplasms: current diagnosticprinciples and upcoming updates
J. T. Geyer et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2016)
VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research
Zhongwu Lai et al.
NUCLEIC ACIDS RESEARCH (2016)
Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features
Laura Palomo et al.
ONCOTARGET (2016)
An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms
Tariq I. Mughal et al.
HAEMATOLOGICA (2015)
An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms
Tariq I. Mughal et al.
HAEMATOLOGICA (2015)
COSMIC: exploring the world's knowledge of somatic mutations in human cancer
Simon A. Forbes et al.
NUCLEIC ACIDS RESEARCH (2015)
Gene mutations differently impact the prognosis of the myelodysplastic and myeloproliferative classes of chronic myelomonocytic leukemia
Nathalie Cervera et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Refined medullary blast and white blood cell count based classification of chronic myelomonocytic leukemias
E. Schuler et al.
LEUKEMIA RESEARCH (2014)
Age-related mutations associated with clonal hematopoietic expansion and malignancies
Mingchao Xie et al.
NATURE MEDICINE (2014)
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia
Esperanza Such et al.
BLOOD (2013)
Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
Raphael Itzykson et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes
M. M. Patnaik et al.
LEUKEMIA (2013)
Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes
Felicitas Thol et al.
BLOOD (2012)
SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)
Manja Meggendorfer et al.
BLOOD (2012)
The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution
Shang-Ju Wu et al.
BLOOD (2012)
SNPeffect 4.0: on-line prediction of molecular and structural effects of protein-coding variants
Greet De Baets et al.
NUCLEIC ACIDS RESEARCH (2012)
Recent advances in diagnosis, molecular pathology and therapy of chronic myelomonocytic leukaemia
Ulrike Bacher et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Frequent pathway mutations of splicing machinery in myelodysplasia
Kenichi Yoshida et al.
NATURE (2011)
Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age
Wendy W. Pang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
RAS Mutations Contribute to Evolution of Chronic Myelomonocytic Leukemia to the Proliferative Variant
Clara Ricci et al.
CLINICAL CANCER RESEARCH (2010)
Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in TET2, CBL, RAS, and RUNX1
Alexander Kohlmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion
Isabel Beerman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia
Olivier Kosmider et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features
A. Orazi et al.
LEUKEMIA (2008)
The World Health Organization (WHO) classification of the myeloid neoplasms
JW Vardiman et al.
BLOOD (2002)